The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The school’s turnaround is one piece of a larger academic ascent in Dallas ISD, which has seen steady gains in student ...

The regulator agreed to allow Sangamo Therapeutics to use data to seek accelerated approval for its Fabry gene therapy ...

"We are thrilled to open our expanded Experience Center, offering cutting-edge resources and training for ophthalmic professionals," said Tom Frinzi, President and CEO of STAAR Surgical.

A Insights and GIST Impact to highlight U.S. companies committed to reducing their environmental impact in key areas like ...

The interim superintendent said the district will use student achievement data to identify and help underperforming students.

Shares of Staar Surgical (STAA) have gained 5.4% over the past four weeks to close the last trading session at $33.87, but there could still be a solid upside left in the stock if short-term price ...

providing resources, and advocating for more research into this rare and recurrent form of ovarian cancer. Verastem Oncology and the STAAR Ovarian Cancer Foundation recognized the first Low-Grade ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

The event overlapped with the Fort Worth ISD school board’s appointment of an interim superintendent. Karen Molinar takes ...

Sangamo Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in Fabry Disease With BLA Submission Expected in 2025 ...